Artisan Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-222,326
Closed -$64.9M 377
2015
Q3
$64.9M Sell
222,326
-191,852
-46% -$63.4M 0.13% 160
2015
Q2
$167M Sell
414,178
-55,755
-12% -$22.4M 0.31% 108
2015
Q1
$198M Sell
469,933
-104,255
-18% -$41.1M 0.36% 94
2014
Q4
$195M Buy
574,188
+83,511
+17% +$27M 0.34% 94
2014
Q3
$162M Buy
490,677
+37,628
+8% +$12.4M 0.29% 113
2014
Q2
$143M Buy
453,049
+124,172
+38% +$37.4M 0.25% 126
2014
Q1
$101M Buy
328,877
+54,821
+20% +$17.4M 0.18% 146
2013
Q4
$76.7M Buy
274,056
+11,776
+4% +$3.05M 0.14% 171
2013
Q3
$63.1M Buy
262,280
+23,064
+10% +$5.16M 0.12% 178
2013
Q2
$51.5M Buy
+239,216
New +$51.1M 0.11% 186

Other funds holding BIIB

Artisan Partners's BIIB Position: Q4 2015 in Review

Artisan Partners sold out of Biogen (BIIB) in Q4 2015, closing a stake of 222,326 shares — an estimated $64.9M sold.

Artisan Partners first reported a position in BIIB in Q2 2013 and held it in 10 quarters. The position peaked at $198M in Q1 2015. 970 funds tracked by Wall St. Rank hold BIIB as of Q4 2015.

  • Artisan Partners reported no remaining Biogen position as of Q4 2015 after selling out during the quarter.
  • Artisan Partners sold 222,326 Biogen shares in Q4 2015, an estimated $64.9M.
  • Artisan Partners first reported a position in Biogen in Q2 2013 and held it in 10 quarters.
  • Artisan Partners's Biogen position peaked at $198M in Q1 2015.
  • 970 funds tracked by Wall St. Rank held Biogen as of Q4 2015.

Based on Artisan Partners's 13F filing for Q4 2015, filed 11 Feb 2016.